Medicated stents may reduce heart attack by delivering the drug to the vessels beyond the stent, according to a study appearing in the September 9 issue of the American Heart Journal. Led by DR Richard Krasuski, researchers from Cleveland Clinic demonstrated that patients receiving medicated stents have a lower likelihood of developing heart attack or [...]
Deposits of cholesterol around the eyelids, which manifest as xanthelasmata, or raised yellow patches of skin, is linked to an increased risk of heart disease or event, and can help identify people at higher risk of heart disease, according to research published September 15 in the British Medical Journal. Researchers at the University of Copenhagen [...]
Only a small number of patients worldwide use effective and low-cost secondary therapies for preventing heart attack or stroke, and the numbers are lowest among low-income countries, reported a study published online on August 28 in The Lancet. An international team of researchers led by Professor Salim Yusuf of McMaster University, Ontario, Canada, conducted the [...]
Following the release of the results of a phase 3B multinational trial showing its efficacy in treating patients with chronic systolic heart failure (HF), eplerenone (Inspra®), an aldosterone antagonist, is now available in Singapore. The Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF) trial showed that eplerenone, when added to Eplerenone [...]
The National Heart Centre Singapore (NHCS) has successfully created beating heart cells from skin using a virus-free method to create human induced pluripotent stem (hiPS) cells. The NHCS research team is able to take skin cells from heart patients to generate hiPS cells, which can then be transformed into beating adult heart muscle cells in [...]
Oral supplementation with a natural form of vitamin E called tocotrienol (TCT) reduced overall brain tissue damage, prevented loss of neural connections and helped sustain blood flow in dogs that had strokes, according to a research study recently published online in the Journal of Cerebral Blood Flow & Metabolism. Researchers say the findings suggest that [...]
A team of local doctors led by Dr Deidre Anne De Silva, consultant at the Department of Neurology, National Neuroscience Institute, is among the 32 winners in the 1 Mission 1 Million – Getting to the Heart of Stroke campaign organised by Boehringer Ingelheim to prevent one million atrial fibrillation strokes across the world through [...]
A study is currently underway to test the feasibility of a system that uses wireless sensors to track the vital signs of patients when they are moving. This study is being conducted at Barnes-Jewish Hospital in St Louis, US, and led by computer scientist Dr Chenyang Lu from the Washington University in St Louis. When [...]
New analyses from SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial) show that ivabradine improves the quality of life in patients with chronic heart failure (CHF), and that this improvement is directly proportional to heart rate reduction. The main SHIFT results, presented at last year’s European Society of Cardiology (ESC) congress, showed [...]
Stent patients who achieve persistently low platelet reactivity have lower risks of cardiovascular events and death, compared to patients with persistently high platelet reactivity. These results were presented at the 2011 European Society of Cardiology Congress recently held in Paris, France. A secondary analysis from the Gauging Responsiveness with A VerifyNow P2Y12 Assay-Impact on Thrombosis [...]